SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-22-000212
Filing Date
2022-03-11
Accepted
2022-03-11 06:28:52
Documents
13
Period of Report
2022-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm   iXBRL 8-K 28998
2 AMENDMENT NO. 4 TO RIGHTS AGREEMENT htbx_ex4z5.htm EX-4.5 13213
  Complete submission text file 0001553350-22-000212.txt   219310

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE htbx-20220311.xsd EX-101.SCH 3048
4 XBRL LABEL FILE htbx-20220311_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE htbx-20220311_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT htbx_8k_htm.xml XML 3607
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 22731063
SIC: 2834 Pharmaceutical Preparations